gsk

    By Melly Alazraki

    | 9:30AM 8/06/2010
    Drug-resistant bacteria has become a pressing public health problem, exacting a rising human and financial toll. GlaxoSmithKline announced that it has found a compound that could help attack such 'superbugs'.

    By Melly Alazraki

    | 5:15PM 7/14/2010
    GlaxoSmithKline diabetes drug Avandia has been found to have increased heart attack risk compared to similar medication. But a majority of the Food and Drug Administration's panel of outside experts have voted to keep the drug on the market -- though new restrictions are likely.

    By Melly Alazraki

    | 5:30PM 9/29/2009
    Just when GlaxoSmithKline (GSK) was set for U.S. Food & Drug Administration approval of its cervical cancer vaccine, tragedy struck in the United Kingdom. Natalie Morton, a 14-year-old British girl, died Monday a few hours after receiving the vaccine, called Cervarix. On Tuesday, the FDA...

    By Melly Alazraki

    | 5:40PM 9/23/2009
    It can sometimes be tough to get a straight answer about any potential problems with drugs from the companies that make them, if court records are any guide. AstraZeneca (AZN) told American doctors the company's antipsychotic drug Seroquel didn't cause diabetes, despite alerting Japanese physicians...

    By Melly Alazraki

    | 2:30PM 8/19/2009
    As if Merck & Co. (MRK) needed more scrutiny of its controversial cervical cancer vaccine, Gardasil. One of the first cancer vaccines on the market, Gardasil combats human papillomavirus -- a sexually transmitted virus contracted by 80 percent of sexually active women by age 50 -- Gardasil was...

    By Melly Alazraki

    | 2:30PM 8/04/2009
    On Friday, shareholders for Merck & Co., Inc. (MRK) and Schering-Plough Corp. (SGP) set to vote on a $41 billion merger. In the meantime, the two companies appear to be doing some house cleaning. One of the first orders when such a deal goes through is to shake up top management, with many...

    By Melly Alazraki

    | 1:30PM 7/02/2009
    It's hard to keep up with the Obama-era Food and Drug Administration. Within the past two weeks alone, the FDA warned that Zicam cold remedy could damage the sense of smell, took aim at lowering the maximum daily dose of acetaminophen, and Wednesday ordered Pfizer Inc (PFE) and GlaxoSmithKline PLC...

    By Melly Alazraki

    | 2:45PM 7/01/2009
    Leave it to a skeptic like me to find something wrong with something that seems ao benevolent. Today, Swiss drug maker Roche Holdings AG (RHHVF) said it will cut the price of its viral drug Tamilflu for developing economies to what would amount to less than half the price it normally charges, and...

    By Melly Alazraki

    | 4:10PM 6/10/2009
    On Tuesday, the World Health Organization's top flu expert said the group is on the verge of declaring the first influenza pandemic in more than 40 years. Confirmed community spread in a second region beyond North America would trigger moving to phase 6, signifying a full-blown pandemic. It's...

    By Melly Alazraki

    | 1:30PM 6/05/2009
    Major drug companies are declining more than the general market today, but none like Merck & Co. (MRK). Merck's shares dropped 2.5 percent on news it won't seek approval this year for its heart-failure drug rolofylline after preliminary results of a Phase III study failed to meet...